Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. (Q31118256)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. |
scientific article |
Statements
1 reference
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. (English)
1 reference
Ursula Schmidt-Erfurth
1 reference
Susan B Bressler
1 reference
Neil M Bressler
1 reference
Jennifer Arnold
1 reference
Mustapha Benchaboune
1 reference
Mark S Blumenkranz
1 reference
Gary E Fish
1 reference
Evangelos S Gragoudas
1 reference
Hilel Lewis
1 reference
Jason S Slakter
1 reference
Kelly Manos
1 reference
Yong Hao
1 reference
Laurie Hayes
1 reference
John Koester
1 reference
Al Reaves
1 reference
H Andrew Strong
1 reference
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference